Neuren Pharmaceuticals Limited
NURPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $15 | $134 | $8 | $109 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$2 |
| Stock-Based Comp. | $1 | $0 | $1 | $2 |
| Change in WC | $155 | -$161 | $4 | -$6 |
| Other Non-Cash | -$42 | $36 | -$33 | $36 |
| Operating Cash Flow | $128 | $9 | -$21 | $140 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | -$211 |
| Inv. Sales/Matur. | $0 | $0 | $1 | $0 |
| Other Inv. Act. | -$86 | $3 | $0 | $47 |
| Investing Cash Flow | -$86 | $3 | $1 | -$164 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $2 | $3 |
| Stock Repurch. | -$40 | -$10 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $2 | $3 |
| Financing Cash Flow | -$38 | -$10 | $2 | $3 |
| Forex Effect | -$2 | -$2 | $4 | $0 |
| Net Chg. in Cash | $6 | -$3 | $3 | -$21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $3 | $0 | $38 |
| End Cash | $6 | $0 | $3 | $17 |
| Free Cash Flow | $128 | $9 | -$21 | $140 |